References
- Ahmed AR, Bodmeier R. 2009. Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading. Eur J Pharm Biopharm. 71:264–270.
- Anderson JM, Shive MS. 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 28:5–24.
- Gokmen MT, Du Prez FE. 2012. Porous polymer particles – a comprehensive guide to synthesis, characterization, functionalization and applications. Prog Polym Sci. 37:365–405.
- Guo C, Guo X, Cai N, Dong Y. 2012. Novel fabrication method of porous poly(lactic acid) scaffold with hydroxyapatite coating. Mater Lett. 74:197–199.
- Imbuluzqueta E, Elizondo E, Gamazo C, Moreno-Calvo E, Veciana J, Ventosa N, Blanco-Prieto JM. 2011. Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections. Acta Biomater. 7:1599–1608.
- Kobsa S, Saltzman WM. 2008. Bioengineering approaches to controlled protein delivery. Pediatr Res. 63:513–519.
- Makadia HK, Siegel SJ. 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery Carrier. Polymers. 3:1377–1397.
- Mittal A, Negi P, Garkhal K, Verma S, Kumar N. 2010. Integration of porosity and bio-functionalization to form a 3D scaffold: cell culture studies and in vitro degradation. Biomed Mater. 5:045001.
- Nanda HS, Kawazoe N, Chen G. 2016. Ionic salt induced morphology and drug release control of insulin incorporated biodegradable PLGA microsphere. AML. 7:866–871.
- Nanda HS, Nakamoto T, Chen S, Cai R, Kawazoe N, Chen G. 2014. Controlled release of bioactive dexamethasone from collagen micro-gel functionalized PLLA scaffold of controlled pore structure for osteogenic differentiation of h-MSCs. J Biomater Sci Polym Ed. 25:1374–1386.